Skip to main content
. 2014 Jul 18;55(5):1214–1221. doi: 10.3349/ymj.2014.55.5.1214

Table 5.

Univariate Analysis of Risk Factors for the Recurrence Free Survival and Progression Free Survival in Patients with Bladder Cancer

graphic file with name ymj-55-1214-i005.jpg

CIS, carcinoma in situ; PUNLMP, papillary urothelial neoplasm of low malignant potential; AR, androgen receptor; ERβ, estrogen receptor beta.